Type 2 Diabetes and Exercise Function in Single Leg Exercises
|ClinicalTrials.gov Identifier: NCT01793909|
Recruitment Status : Completed
First Posted : February 18, 2013
Last Update Posted : June 8, 2018
This study plans to learn more about the effects of type 2 diabetes (T2DM) on exercise blood flow and muscle oxygen uptake. This study will evaluate & compare exercise function during single leg plantar flexion exercise in a total of 45 subjects from the Denver area (15 lean controls, 15 people with T2DM, and 15 overweight control subjects).
Differences between the exercise responses in people with T2DM and healthy people will help further identify the disease process of T2DM and direct future research of treatments and interventions.
|Condition or disease||Intervention/treatment||Phase|
|Type 2 Diabetes||Other: Single Leg Exercise Training||Not Applicable|
It is well established that functional exercise capacity and peak oxygen uptake (VO2) are reduced in patients with type 2 diabetes mellitus (T2DM) compared with healthy counterparts. The mechanisms underlying the exercise deficit in T2DM remain largely unknown, but previous work has suggested that reduced exercise blood flow and impaired submaximal VO2 may be contributing factors. Both of these findings are consistent with a peripheral impairment of skeletal muscle oxygen delivery, oxygen utilization, or both. Indeed, dysfunction of skeletal muscle metabolism plays a key role in the pathophysiology of T2DM, and considerable work has described abnormalities of oxidative function in the skeletal muscle of people with T2DM. Given this, it is likely that the causes of exercise intolerance in T2DM may relate to specific defects at the level of the skeletal muscle, particularly given that skeletal muscle blood flow and oxidative capacity are impaired in diabetes. However, to our knowledge, no one has related these peripheral muscle abnormalities to the diminished exercise function in this patient group.
The overarching hypothesis for the proposed research is that both a failure to adequately increase muscle oxygen delivery following the onset of exercise and reduced oxidative function of skeletal muscle contribute to the acute oxygen deficit and diminished exercise tolerance that has been observed in patients with T2DM.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||43 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Role of Vascular Function: Oxygen Delivery vs Oxygen Utilization in the Exercise Impairment in Type 2 Diabetes|
|Study Start Date :||June 2012|
|Actual Primary Completion Date :||May 31, 2018|
|Actual Study Completion Date :||May 31, 2018|
Single Leg Exercise
Supervised single leg, exercise training of the index (dominant) calf muscle 5 days per week for two weeks - alternating weight-bearing single leg calf raises and single leg calf extensions by endurance resistance training (weight machine apparatus).
Other: Single Leg Exercise Training
Following the completion of baseline testing, all 3 subject groups will undergo supervised single leg, exercise training of the index (dominant) calf muscle 5 days per week for two weeks - alternating weight-bearing single leg calf raises and single leg calf extensions by endurance resistance training (weight machine apparatus).
Other Name: Exercise Training
- Change in Oxygen delivery/Muscle utilization [ Time Frame: 4.5 hrs each, pre- and post- Exercise Intervention ]The investigators will evaluate the dynamics of leg blood flow (and thus oxygen delivery) using Doppler ultrasound, muscle deoxygenation (O2 extraction) using near infrared spectroscopy (NIRS), and pulmonary VO2 during single leg plantar flexion exercise to identify the predominant mechanisms of oxygen delivery versus oxygen utilization abnormalities in the muscle of T2DM during the transition from rest to exercise. These measurements will be gathered continuously for 2-5 minutes of multiple exercise bouts within two visits, one prior to the exercise intervention period and one post exercise intervention. This innovative set of experiments will be the beginning of an important link between metabolic abnormalities of T2DM and exercise capacity.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01793909
|United States, Colorado|
|University of Colorado Denver, Anschutz Medical Campus|
|Aurora, Colorado, United States, 80045|
|Principal Investigator:||Judy Regensteiner, PhD||University of Colorado, Denver|